Healthy Technology Act of 2025

Bill: 119-hr-238
Sponsor: full_name: Rep. Schweikert, David [R-AZ-1]
Introduced: 2025-01-07
Policy area: Health
Subjects: Advanced technology and technological innovations

Health personnel

Health technology, devices, supplies

Prescription drugs
Latest action: action_date: 2025-01-07
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2025-01-07
action_desc: Introduced in House
text: <p><strong>Healthy Technology Act of 2025 </strong></p><p>This bill establishes that artificial intelligence (AI) or machine learning technology may be eligible to prescribe drugs.</p><p>Currently, certain drugs may be dispensed only upon a prescription provided by a practitioner licensed by law to administer the drug. Under this bill, an AI or machine learning technology may qualify as such a prescribing practitioner if the technology is (1) authorized by state law to prescribe the drug involved; and (2) approved, cleared, or authorized under certain federal provisions pertaining to medical devices and products.</p>

tv_txt: I 119th CONGRESS 1st Session H. R. 238 IN THE HOUSE OF REPRESENTATIVES January 7, 2025 Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.

1. Short title This Act may be cited as the Healthy Technology Act of 2025 . 2. Prescription of drugs by artificial intelligence or machine learning technologies Section 503(b) of Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353(b) ) is amended by adding at the end the following: (6) In this subsection, the term practitioner licensed by law to administer such drug includes artificial intelligence and machine learning technology that are— (A) authorized pursuant to a statute of the State involved to prescribe the drug involved; and (B) approved, cleared, or authorized under section 510(k), 513, 515, or 564. .